Rabaiya Fatima Ali, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 385 S Orange St, El Paso, IL 61738 Phone: 309-527-4900 |
Dr. Colby Lee Carr, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 385 S Orange St, El Paso, IL 61738 Phone: 309-527-4900 |
Dr. Paul E. Hakes, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 385 S Orange St, El Paso, IL 61738 Phone: 309-527-4900 Fax: 309-527-3525 |
Dr. Steven C. Ingalsbe, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 385 S Orange St, El Paso, IL 61738 Phone: 309-527-4900 Fax: 309-527-3525 |
News Archive
The Guardian examines efforts to reduce malaria in Katine, Uganda, through the distribution of insecticide-treated nets to high-risk groups. Though the article details a reduction in the number of malaria cases in the region, additional nets are needed to cover the entire population. Also, health experts warn additional strategies, such as indoor residual spraying and increased access to drugs are needed to defeat malaria (Kavuma, 10/8).
PSR announced today the launch of its new service and dedicated website, OrphanIQ. OrphanIQ is a quick and easy way for companies involved in Orphan Drug development to ask a short question on a variety of topics without the need for setting up time-consuming agreements and contracts. Questions will be handled by the relevant expert, who will first assess whether the question can be answered without obtaining further information, and within a reasonable time-frame, and will subsequently provide a written answer.
According to the latest study, fewer Australian pre-schoolers are overweight in recent years compared with the late-1990s and also the social disparities in children's obesity risk seem to be shrinking. These findings were reported in the International Journal of Obesity.
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT drug delivery technology and internal pipeline through out-licensing arrangements and partnerships, today announced results from a pre-clinical pharmacokinetic study showing the ability of NexACT to enable rectal delivery of biologics, such as human antibodies.
› Verified 9 days ago